Welcome to Medivizor!

You're browsing our sample library. Feel free to continue browsing. You can also sign up for free to receive medical information specific to your situation.

Posted by on Feb 24, 2013 in Breast cancer | 0 comments

In a nutshell

The present study evaluated whether the presence of cancer cells in the blood stream predicts a worse prognosis in women with operable breast cancer. The main finding was that progression-free survival (time before cancer progression) and overall survival were lower if circulating cancer cells were detected in the blood.

Some background

Detection of tumor cells in the blood (‘circulating’) is a relatively new technique which may help identify high risk groups among breast cancer patients. The test is performed by drawing a small quantity of blood (7.5 ml). It is hypothesized that these microscopic cells are responsible for cancer recurrence and spread to other organs. Previous studies revealed that around 20% of breast cancer patients may have tumor cells in the blood stream in the early stages of the disease.

Methods & findings

The present study included 302 patients (with stage 1-3 breast cancer) undergoing surgery only (either partial or total mastectomy) to treat breast cancer. Participants did not receive previous chemotherapy. 7.5 ml of blood was collected from each patient to be analyzed for the presence of cancer cells. 24% of the patients had at least one circulating tumor cell in the blood sample, while 5% had three or more. After an average follow-up of 35 months, progression-free survival (time before cancer progress or reoccur) was lower in patients with circulating tumor cells. Overall survival was also decreased in the presence of circulating cancer cells. These results were proportional to the number of tumor cells found in the blood sample.

The bottom line

The findings suggest that some patients have a higher risk of cancer recurrence which is not related to the cancer stage. By detecting circulating tumor cells in the blood stream, these patients may receive different chemotherapy regimens to improve their survival and lower the risk of cancer recurrence.

The fine print

Larger studies are still needed to see if this test will indeed improve breast cancer prognosis.

Published By :

Lancet oncology

Date :

Jul 01, 2012

Original Title :

Circulating tumour cells in non-metastatic breast cancer: a prospective study

click here to get personalized updates